Preeclampsia and fetal well-being

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Perinatology

Background:

• Preeclamptic toxemia poses significant risks to both mother and fetus.
• Accurate classification of preeclamptic toxemia is essential for appropriate management.
• Existing classification methods may not fully capture fetal well-being.

Purpose of the Study:

• To propose a novel classification system for preeclamptic toxemia.
• To stratify patients based on fetal growth, fetal movement, and fetal heart recordings.
• To guide clinical management decisions for preeclamptic pregnancies.

Main Methods:

• Retrospective analysis of 33 women with preeclamptic toxemia.
• Division into three groups based on clinical data, urinary estriol, fetal growth, fetal movements, and fetal heart recordings.
• Assessment of fetal well-being parameters.

Main Results:

• Group 1: Normal fetal growth and well-being.
• Group 2: Fetal growth retardation with low estriol, normal fetal movement/heart rate (placental metabolic failure).
• Group 3: Decreased fetal movements and pathological fetal heart recordings (severe fetal distress).

Conclusions:

• A new classification for preeclamptic toxemia is suggested based on fetal status.
• Group 2 patients require observation; prompt delivery is indicated for Group 3 patients to prevent intrauterine fetal demise.